Zheng H, Chen Y, Xu Y, Cen C, Wang Y
J Transl Med. 2023; 21(1):896.
PMID: 38072957
PMC: 10712130.
DOI: 10.1186/s12967-023-04583-9.
Negus S, Akbarali H, Kang M, Lee Y, Marsh S, Santos E
Front Pain Res (Lausanne). 2023; 4:1281698.
PMID: 37886350
PMC: 10598607.
DOI: 10.3389/fpain.2023.1281698.
Inyang K, Evans C, Heussner M, Petroff M, Reimers M, Vermeer P
Pain. 2023; 165(3):608-620.
PMID: 37678566
PMC: 10915104.
DOI: 10.1097/j.pain.0000000000003045.
Noble D, Dongmo R, Parvin S, Martin K, Garraway S
Front Integr Neurosci. 2023; 16:1081172.
PMID: 36619238
PMC: 9811591.
DOI: 10.3389/fnint.2022.1081172.
Martin K, Noble D, Parvin S, Jang K, Garraway S
Front Cell Neurosci. 2022; 16:987236.
PMID: 36226073
PMC: 9548551.
DOI: 10.3389/fncel.2022.987236.
Contextual control of conditioned pain tolerance and endogenous analgesic systems.
Trask S, Mogil J, Helmstetter F, Stucky C, Sadler K
Elife. 2022; 11.
PMID: 35275062
PMC: 8937231.
DOI: 10.7554/eLife.75283.
Magnetic Ligand Fishing Using Immobilized Cyclooxygenase-2 for Identification and Screening of Anticoronary Heart Disease Ligands From .
Chi M, Wang H, Yan Z, Cao L, Gao X, Qin K
Front Nutr. 2022; 8:794193.
PMID: 35174196
PMC: 8841743.
DOI: 10.3389/fnut.2021.794193.
Behavioral Battery for Testing Candidate Analgesics in Mice. I. Validation with Positive and Negative Controls.
Diester C, Santos E, Moerke M, Negus S
J Pharmacol Exp Ther. 2021; 377(2):232-241.
PMID: 33622770
PMC: 8058504.
DOI: 10.1124/jpet.120.000464.
Resistance of Food-Maintained Operant Responding to Mechanical Punishment in Rats: Further Evidence for Weak "Affective/Motivational Pain" in Rat Models of Inflammatory and Neuropathic Pain.
Negus S, Marsh S, Townsend E
Front Pharmacol. 2021; 11:615782.
PMID: 33584295
PMC: 7878562.
DOI: 10.3389/fphar.2020.615782.
Kappa Opioid Signaling at the Crossroads of Chronic Pain and Opioid Addiction.
Cahill C, Lueptow L, Kim H, Shusharla R, Bishop A, Evans C
Handb Exp Pharmacol. 2021; 271:315-350.
PMID: 33547588
PMC: 9436635.
DOI: 10.1007/164_2021_434.
Factors mediating pain-related risk for opioid use disorder.
Nazarian A, Negus S, Martin T
Neuropharmacology. 2021; 186:108476.
PMID: 33524407
PMC: 7954943.
DOI: 10.1016/j.neuropharm.2021.108476.
Antinociceptive Effects of Kappa-Opioid Receptor Agonists.
Lazenka M
Handb Exp Pharmacol. 2021; 271:293-313.
PMID: 33387069
DOI: 10.1007/164_2020_430.
Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development.
Koob G
Pharmacol Rev. 2020; 73(1):163-201.
PMID: 33318153
PMC: 7770492.
DOI: 10.1124/pharmrev.120.000083.
Pain, Motivation, Migraine, and the Microbiome: New Frontiers for Opioid Systems and Disease.
Parker K, Sugiarto E, Taylor A, Pradhan A, Al-Hasani R
Mol Pharmacol. 2020; 98(4):433-444.
PMID: 32958571
PMC: 7562975.
DOI: 10.1124/mol.120.119438.
Effects of repeated treatment with monoamine-transporter-inhibitor antidepressants on pain-related depression of intracranial self-stimulation in rats.
Legakis L, Karim-Nejad L, Negus S
Psychopharmacology (Berl). 2020; 237(7):2201-2212.
PMID: 32382785
PMC: 7308219.
DOI: 10.1007/s00213-020-05530-y.
The antinociceptive effects of a dual kappa-delta opioid receptor agonist in the mouse formalin test.
Ulker E, Toma W, White A, Uprety R, Majumdar S, Damaj M
Behav Pharmacol. 2020; 31(2&3):174-178.
PMID: 32168026
PMC: 7080317.
DOI: 10.1097/FBP.0000000000000541.
Neuropathic insult increases the responsiveness to acetic acid in mice.
Gurdap C, Markwalter Jr P, Neddenriep B, Bagdas D, Damaj M
Behav Pharmacol. 2019; 30(6):534-537.
PMID: 31033524
PMC: 6684379.
DOI: 10.1097/FBP.0000000000000486.
Core Outcome Measures in Preclinical Assessment of Candidate Analgesics.
Negus S
Pharmacol Rev. 2019; 71(2):225-266.
PMID: 30898855
PMC: 6448246.
DOI: 10.1124/pr.118.017210.
Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain.
Liu S, Pickens S, Burma N, Ibarra-Lecue I, Yang H, Xue L
J Neurosci. 2019; 39(21):4162-4178.
PMID: 30862664
PMC: 6529867.
DOI: 10.1523/JNEUROSCI.0274-19.2019.
Rapid screening and identification of bioactive compounds specifically binding to beta 2-adrenoceptor from San-ao decoction using affinity magnetic fine particles coupled with high-performance liquid chromatography-mass spectrometry.
Fei F, Sun H, Cheng X, Liu J, Wang J, Li Q
Chin Med. 2018; 13:49.
PMID: 30258489
PMC: 6154427.
DOI: 10.1186/s13020-018-0207-8.